Your browser doesn't support javascript.
loading
Characteristics of COVID-19 in patients with multiple sclerosis.
Ghadiri, Fereshteh; Sahraian, Mohammad Ali; Shaygannejad, Vahid; Ashtari, Fereshteh; Ghalyanchi Langroodi, Hamidreza; Baghbanian, Seyed Mohammad; Mozhdehipanah, Hossein; Majdi-Nasab, Nastaran; Hosseini, Samaneh; Poursadeghfard, Maryam; Beladimoghadam, Nahid; Razazian, Nazanin; Ayoubi, Saeideh; Rezaeimanesh, Nasim; Eskandarieh, Sharareh; Naser Moghadasi, Abdorreza.
Affiliation
  • Ghadiri F; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Sahraian MA; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Shaygannejad V; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Ashtari F; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Ghalyanchi Langroodi H; Center for Clinical Research and development, Ghaem Int. Hospital, Rasht, Iran.
  • Baghbanian SM; Department of Neurology, Booalicina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
  • Mozhdehipanah H; Department of Neurology, Qazvin University of Medical Sciences, Qazvin, Iran.
  • Majdi-Nasab N; Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Hosseini S; Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Poursadeghfard M; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Beladimoghadam N; Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Razazian N; Department of Neurology, Medicine Faculty, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Ayoubi S; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Rezaeimanesh N; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Eskandarieh S; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: sh_eskandarieh@yahoo.com.
  • Naser Moghadasi A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: abdorrezamoghadasi@gmail.com.
Mult Scler Relat Disord ; 57: 103437, 2022 Jan.
Article de En | MEDLINE | ID: mdl-34896875
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Sclérose en plaques Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Mult Scler Relat Disord Année: 2022 Type de document: Article Pays d'affiliation: Iran
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Sclérose en plaques Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Mult Scler Relat Disord Année: 2022 Type de document: Article Pays d'affiliation: Iran